{"id":2205,"date":"2023-03-27T00:00:00","date_gmt":"2023-03-27T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2205"},"modified":"2023-03-27T00:00:00","modified_gmt":"2023-03-27T00:00:00","slug":"a-iqvia-e-a-centogene-firmam-parceria-para-melhorar-os-resultados-de-saude-para-pacientes-com-doencas-raras","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/pt\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/","title":{"rendered":"IQVIA e CENTOGENE firmam parceria para melhorar os resultados de sa\u00fade de pacientes com doen\u00e7as raras."},"content":{"rendered":"<p><strong>CAMBRIDGE, Massachusetts, ROSTOCK, Alemanha e BERLIM, 28 de mar\u00e7o de 2023 <\/strong>A IQVIA e a CENTOGENE firmaram uma colabora\u00e7\u00e3o para melhorar os resultados de sa\u00fade de pacientes com doen\u00e7as raras, acelerando e reduzindo os riscos do desenvolvimento cl\u00ednico e ampliando o acesso a testes gen\u00e9ticos. Por meio da combina\u00e7\u00e3o de recursos em dados do mundo real e solu\u00e7\u00f5es de parceria escal\u00e1veis, essa colabora\u00e7\u00e3o fornecer\u00e1 suporte integral para viabilizar melhores resultados de sa\u00fade, desde a medicina de precis\u00e3o at\u00e9 a descoberta, o desenvolvimento e a comercializa\u00e7\u00e3o de medicamentos baseados em dados. Acelerar e simplificar os ensaios cl\u00ednicos e as op\u00e7\u00f5es de testes gen\u00e9ticos \u00e9 fundamental para levar novas solu\u00e7\u00f5es inovadoras aos pacientes da maneira mais eficiente poss\u00edvel.<\/p>\n<h3>Sobre a CENTOGENE&nbsp;<\/h3>\n<p>A miss\u00e3o da CENTOGENE \u00e9 fornecer respostas transformadoras e baseadas em dados para pacientes, m\u00e9dicos e empresas farmac\u00eauticas no que diz respeito a doen\u00e7as raras e neurodegenerativas. Integramos tecnologias multi\u00f4micas ao Biobanco CENTOGENE, oferecendo an\u00e1lises dimensionais para orientar a pr\u00f3xima gera\u00e7\u00e3o da medicina de precis\u00e3o. Nossa abordagem exclusiva possibilita diagn\u00f3sticos r\u00e1pidos e confi\u00e1veis para pacientes, apoia uma compreens\u00e3o mais precisa dos estados da doen\u00e7a por parte dos m\u00e9dicos e acelera e reduz os riscos da descoberta, desenvolvimento e comercializa\u00e7\u00e3o de medicamentos direcionados.&nbsp;<\/p>\n<p>Desde a nossa funda\u00e7\u00e3o em 2006, a CENTOGENE oferece diagn\u00f3sticos r\u00e1pidos e confi\u00e1veis, construindo uma rede de aproximadamente 30.000 m\u00e9dicos ativos. Nossos laborat\u00f3rios de refer\u00eancia multi\u00f4mica certificados pela ISO, CAP e CLIA, na Alemanha, utilizam conjuntos de dados fen\u00f4micos, gen\u00f4micos, transcript\u00f4micos, epigen\u00f4micos, prote\u00f4micos e metabol\u00f4micos. Esses dados s\u00e3o armazenados em nosso Biobanco CENTOGENE, que representa quase 700.000 pacientes de mais de 120 pa\u00edses, dos quais mais de 701.000 s\u00e3o de ascend\u00eancia n\u00e3o europeia. At\u00e9 o momento, o Biobanco CENTOGENE contribuiu para a gera\u00e7\u00e3o de novos conhecimentos em mais de 260 publica\u00e7\u00f5es revisadas por pares.<\/p>\n<p>Ao traduzir nossos dados e experi\u00eancia em insights tang\u00edveis, apoiamos mais de 50 colabora\u00e7\u00f5es com parceiros da ind\u00fastria farmac\u00eautica. Juntos, aceleramos e reduzimos os riscos da descoberta, desenvolvimento e comercializa\u00e7\u00e3o de medicamentos em \u00e1reas como triagem de alvos e f\u00e1rmacos, desenvolvimento cl\u00ednico, acesso e expans\u00e3o de mercado, al\u00e9m de oferecermos Licen\u00e7as do Biobanco CENTOGENE e Relat\u00f3rios de Insights para possibilitar um mundo livre de todas as doen\u00e7as raras e neurodegenerativas.&nbsp;<\/p>\n<p>Para saber mais sobre nossos produtos, projetos em desenvolvimento e prop\u00f3sito centrado no paciente, visite [link]. <a href=\"t3:\/\/page?uid=1\">www.centogene.com<\/a> e siga-nos em <a href=\"https:\/\/www.linkedin.com\/company\/centogene\/\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<h3>Declara\u00e7\u00f5es prospectivas&nbsp;<\/h3>\n<p>Este comunicado de imprensa cont\u00e9m &quot;declara\u00e7\u00f5es prospectivas&quot; conforme definido pelas leis federais de valores mobili\u00e1rios dos EUA. Declara\u00e7\u00f5es aqui contidas que n\u00e3o sejam claramente de natureza hist\u00f3rica s\u00e3o prospectivas, e palavras como &quot;antecipar&quot;, &quot;acreditar&quot;, &quot;continuar&quot;, &quot;esperar&quot;, &quot;estimar&quot;, &quot;pretender&quot;, &quot;projetar&quot; e express\u00f5es semelhantes, bem como verbos no futuro ou no condicional, como &quot;ir\u00e1&quot;, &quot;poderia&quot;, &quot;deveria&quot;, &quot;conseguiria&quot;, &quot;talvez&quot;, &quot;pode&quot; e &quot;pode&quot;, geralmente s\u00e3o utilizadas para identificar declara\u00e7\u00f5es prospectivas. Tais declara\u00e7\u00f5es prospectivas envolvem riscos conhecidos e desconhecidos, incertezas e outros fatores importantes que podem fazer com que os resultados, o desempenho ou as conquistas reais da CENTOGENE sejam materialmente diferentes de quaisquer resultados, desempenho ou conquistas futuros expressos ou impl\u00edcitos nas declara\u00e7\u00f5es prospectivas. Tais riscos e incertezas incluem, entre outros, condi\u00e7\u00f5es econ\u00f4micas e geopol\u00edticas negativas, instabilidade e volatilidade nos mercados financeiros mundiais, poss\u00edveis mudan\u00e7as na legisla\u00e7\u00e3o, regulamenta\u00e7\u00e3o e pol\u00edticas governamentais atuais e propostas, press\u00f5es decorrentes do aumento da concorr\u00eancia e consolida\u00e7\u00e3o em nosso setor, o custo e a incerteza da aprova\u00e7\u00e3o regulat\u00f3ria, inclusive da Food and Drug Administration (FDA) dos EUA, nossa depend\u00eancia de terceiros e parceiros de colabora\u00e7\u00e3o, incluindo nossa capacidade de gerenciar o crescimento, executar nossa estrat\u00e9gia de neg\u00f3cios e estabelecer novos relacionamentos com clientes, nossa depend\u00eancia do setor de doen\u00e7as raras, nossa capacidade de gerenciar a expans\u00e3o internacional, nossa depend\u00eancia de pessoal-chave, nossa depend\u00eancia da prote\u00e7\u00e3o da propriedade intelectual, flutua\u00e7\u00f5es em nossos resultados operacionais devido ao efeito das taxas de c\u00e2mbio, nossa capacidade de otimizar o uso de caixa, nossa cont\u00ednua conformidade com as cl\u00e1usulas contratuais vinculadas a instrumentos financeiros, nossa necessidade de financiamento adicional ou outros fatores. Para obter mais informa\u00e7\u00f5es sobre os riscos e incertezas que podem fazer com que os resultados reais sejam diferentes daqueles expressos nessas declara\u00e7\u00f5es prospectivas, bem como sobre os riscos relacionados aos neg\u00f3cios da CENTOGENE em geral, consulte os fatores de risco da CENTOGENE descritos no Formul\u00e1rio 20-F da CENTOGENE, arquivado em 31 de mar\u00e7o de 2022 junto \u00e0 Comiss\u00e3o de Valores Mobili\u00e1rios dos EUA (a \u201cSEC\u201d), e em arquivamentos subsequentes junto \u00e0 SEC. Quaisquer declara\u00e7\u00f5es prospectivas contidas neste comunicado \u00e0 imprensa referem-se apenas \u00e0 data deste documento, e a CENTOGENE se isenta especificamente de qualquer obriga\u00e7\u00e3o de atualizar qualquer declara\u00e7\u00e3o prospectiva, seja como resultado de novas informa\u00e7\u00f5es, eventos futuros ou outros fatores.&nbsp;<\/p>\n<h5>CONTATO<\/h5>\n<p>CENTOGENE&nbsp;<br \/> Ben Legg<br \/> Comunica\u00e7\u00e3o Corporativa<br \/> <a href=\"mailto:Press@centogene.com\" title=\"Ben Legg\">Press(at)centogene(dot)com<\/a><\/p>\n<p>Lennart Streibel<br \/> Rela\u00e7\u00f5es com Investidores<br \/> <a href=\"mailto:IR@centogene.com\" title=\"Lennart Streibel\">IR(at)centogene(dot)com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>A IQVIA e a CENTOGENE firmaram uma colabora\u00e7\u00e3o para melhorar os resultados de sa\u00fade de pacientes com doen\u00e7as raras, acelerando e reduzindo os riscos do desenvolvimento cl\u00ednico e aumentando o acesso a testes gen\u00e9ticos.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2205","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/pt\/a-iqvia-e-a-centogene-firmam-parceria-para-melhorar-os-resultados-de-saude-para-pacientes-com-doencas-raras\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"IQVIA and CENTOGENE have formed a collaboration to improve health outcomes for rare disease patients by accelerating and de-risking clinical development and increasing access to genetic testing.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/pt\/a-iqvia-e-a-centogene-firmam-parceria-para-melhorar-os-resultados-de-saude-para-pacientes-com-doencas-raras\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients\",\"datePublished\":\"2023-03-27T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/\"},\"wordCount\":703,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/\",\"name\":\"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2023-03-27T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/pt\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IQVIA e CENTOGENE firmam parceria para melhorar os resultados de sa\u00fade de pacientes com doen\u00e7as raras | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/pt\/a-iqvia-e-a-centogene-firmam-parceria-para-melhorar-os-resultados-de-saude-para-pacientes-com-doencas-raras\/","og_locale":"pt_BR","og_type":"article","og_title":"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients | CENTOGENE","og_description":"IQVIA and CENTOGENE have formed a collaboration to improve health outcomes for rare disease patients by accelerating and de-risking clinical development and increasing access to genetic testing.","og_url":"https:\/\/www.centogene.com\/pt\/a-iqvia-e-a-centogene-firmam-parceria-para-melhorar-os-resultados-de-saude-para-pacientes-com-doencas-raras\/","og_site_name":"CENTOGENE","article_published_time":"2023-03-27T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients","datePublished":"2023-03-27T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/"},"wordCount":703,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/","url":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/","name":"IQVIA e CENTOGENE firmam parceria para melhorar os resultados de sa\u00fade de pacientes com doen\u00e7as raras | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2023-03-27T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/iqvia-and-centogene-form-collaboration-to-improve-health-outcomes-for-rare-disease-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"IQVIA and CENTOGENE Form Collaboration to Improve Health Outcomes for Rare Disease Patients"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Orientando a Medicina de Precis\u00e3o","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"admincg","url":"https:\/\/www.centogene.com\/pt\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/posts\/2205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/comments?post=2205"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/posts\/2205\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/media?parent=2205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/categories?post=2205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/pt\/wp-json\/wp\/v2\/tags?post=2205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}